The MerR-like regulator BrlR impairs Pseudomonas aeruginosa biofilm tolerance to colistin by repressing PhoPQ

scientific journal article

The MerR-like regulator BrlR impairs Pseudomonas aeruginosa biofilm tolerance to colistin by repressing PhoPQ is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/JB.00834-13
P932PMC publication ID3807428
P698PubMed publication ID23935054

P2093author name stringKarin Sauer
Jacob R. Chambers
P2860cites workExtracellular DNA chelates cations and induces antibiotic resistance in Pseudomonas aeruginosa biofilmsQ21090518
Microbial biofilms: from ecology to molecular geneticsQ21999032
Microbial biofilmsQ22255624
Biofilms: survival mechanisms of clinically relevant microorganismsQ22299328
Pseudomonas aeruginosa displays multiple phenotypes during development as a biofilmQ24538827
The transition metal gallium disrupts Pseudomonas aeruginosa iron metabolism and has antimicrobial and antibiofilm activityQ24683150
Bacterial biofilms: a common cause of persistent infectionsQ27861033
Determination of minimum inhibitory concentrationsQ28203149
Bacterial Biofilms: An Emerging Link to Disease PathogenesisQ28207244
Antibiotic resistance of bacteria in biofilmsQ28207706
A novel signaling network essential for regulating Pseudomonas aeruginosa biofilm developmentQ28471924
The two-component system CprRS senses cationic peptides and triggers adaptive resistance in Pseudomonas aeruginosa independently of ParRSQ28492572
Cationic antimicrobial peptides activate a two‐component regulatory system, PmrA‐PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosaQ28492717
Adaptive resistance to the "last hope" antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel two-component regulatory system ParR-ParSQ28493107
The MerR-like transcriptional regulator BrlR contributes to Pseudomonas aeruginosa biofilm toleranceQ28493235
Comprehensive transposon mutant library of Pseudomonas aeruginosaQ29614861
Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patientsQ29615301
Active starvation responses mediate antibiotic tolerance in biofilms and nutrient-limited bacteriaQ33716417
Antimicrobial resistance of Pseudomonas aeruginosa biofilmsQ33973957
Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacinQ33979968
Characterization of phenotypic changes in Pseudomonas putida in response to surface-associated growthQ33996997
Role of membranes in the activities of antimicrobial cationic peptidesQ34111592
Parallel evolution in Pseudomonas aeruginosa over 39,000 generations in vivo.Q34128914
Colistin-tobramycin combinations are superior to monotherapy concerning the killing of biofilm Pseudomonas aeruginosaQ34143161
Characterization of temporal protein production in Pseudomonas aeruginosa biofilmsQ34150961
Probing prokaryotic social behaviors with bacterial "lobster traps"Q34285911
The single-nucleotide resolution transcriptome of Pseudomonas aeruginosa grown in body temperatureQ34426518
Role of nutrient limitation and stationary-phase existence in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacinQ34884476
Pseudomonas aeruginosa: resistance to the maxQ35084559
Characterization of colony morphology variants isolated from Streptococcus pneumoniae biofilmsQ35759418
Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infectionsQ36095874
The agmR gene, an environmentally responsive gene, complements defective glpR, which encodes the putative activator for glycerol metabolism in Pseudomonas aeruginosaQ36164134
Formation of Streptococcus pneumoniae non-phase-variable colony variants is due to increased mutation frequency present under biofilm growth conditionsQ36933242
The MerR-like regulator BrlR confers biofilm tolerance by activating multidrug efflux pumps in Pseudomonas aeruginosa biofilmsQ37035909
P. aeruginosa Biofilms in CF InfectionQ37176167
Characterization of nutrient-induced dispersion in Pseudomonas aeruginosa PAO1 biofilmQ37583328
Influence of growth rate on susceptibility to antimicrobial agents: biofilms, cell cycle, dormancy, and stringent responseQ38037106
Contribution of the PhoP-PhoQ and PmrA-PmrB two-component regulatory systems to Mg2+-induced gene regulation in Pseudomonas aeruginosa.Q38313207
Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-oprM efflux pumps in Pseudomonas aeruginosaQ39475663
Interactions between biocide cationic agents and bacterial biofilmsQ39651576
Microbial characterization of biofilms in domestic drains and the establishment of stable biofilm microcosmsQ39743016
Involvement of a novel efflux system in biofilm-specific resistance to antibioticsQ39759278
Two-component regulatory systems can interact to process multiple environmental signalsQ39843585
Dynamic interactions of biofilms of mucoid Pseudomonas aeruginosa with tobramycin and piperacillinQ39874925
Genome macrorestriction analysis of diversity and variability of Pseudomonas aeruginosa strains infecting cystic fibrosis patients.Q40188725
Outer membrane protein H1 of Pseudomonas aeruginosa: involvement in adaptive and mutational resistance to ethylenediaminetetraacetate, polymyxin B, and gentamicinQ40336613
PmrAB, a two-component regulatory system of Pseudomonas aeruginosa that modulates resistance to cationic antimicrobial peptides and addition of aminoarabinose to lipid AQ40387809
PAS domain residues and prosthetic group involved in BdlA-dependent dispersion response by Pseudomonas aeruginosa biofilmsQ41583285
The novel two-component regulatory system BfiSR regulates biofilm development by controlling the small RNA rsmZ through CafAQ42161859
Pseudomonas aeruginosa cross-colonization and persistence in patients with cystic fibrosis. Use of a DNA probeQ42232660
PhoP-PhoQ homologues in Pseudomonas aeruginosa regulate expression of the outer-membrane protein OprH and polymyxin B resistanceQ42613861
In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolatesQ42948712
Persister cells and tolerance to antimicrobialsQ44735515
Broad-host-range expression vectors that carry the L-arabinose-inducible Escherichia coli araBAD promoter and the araC regulatorQ47987335
Comparison of the PhoPQ regulon in Escherichia coli and Salmonella typhimuriumQ50091022
Role of Pseudomonas aeruginosa PhoP-phoQ in resistance to antimicrobial cationic peptides and aminoglycosides.Q54034376
Interactions of an antimicrobial peptide, magainin 2, with outer and inner membranes of Gram-negative bacteriaQ54562301
Characterization and use of a DNA probe as an epidemiological marker for Pseudomonas aeruginosaQ70316490
Peptide antibioticsQ73073957
Membrane permeabilization mechanisms of a cyclic antimicrobial peptide, tachyplesin I, and its linear analogQ73561279
P433issue20
P407language of work or nameEnglishQ1860
P921main subjectPseudomonas aeruginosaQ31856
colistinQ418946
biofilmQ467410
P304page(s)4678–4688
P577publication date2013-10-01
P1433published inJournal of BacteriologyQ478419
P1476titleThe MerR-like regulator BrlR impairs Pseudomonas aeruginosa biofilm tolerance to colistin by repressing PhoPQ
P478volume195

Reverse relations

cites work (P2860)
Q37552351Advances in understanding Pseudomonas
Q29346796BrlR from Pseudomonas aeruginosa is a c-di-GMP-responsive transcription factor
Q55517510BrlR from Pseudomonas aeruginosa is a receptor for both cyclic di-GMP and pyocyanin.
Q57944093Chronic tonsillitis and biofilms: a brief overview of treatment modalities
Q92302893Clinical Use of Colistin in Biofilm-Associated Infections
Q47098155Divide and conquer: the Pseudomonas aeruginosa two-component hybrid SagS enables biofilm formation and recalcitrance of biofilm cells to antimicrobial agents via distinct regulatory circuits
Q41036943Efflux-mediated resistance to a benzothiadiazol derivative effective against Burkholderia cenocepacia
Q92302854Mechanisms of Polymyxin Resistance
Q64910479Molecular mechanisms related to colistin resistance in Enterobacteriaceae.
Q40975034Osteoarticular infection caused by MDR Pseudomonas aeruginosa: the benefits of combination therapy with colistin plus β-lactams
Q42027703Polymyxin Susceptibility in Pseudomonas aeruginosa Linked to the MexXY-OprM Multidrug Efflux System
Q38922536Polymyxin: Alternative Mechanisms of Action and Resistance.
Q37589273Rapid adaptation drives invasion of airway donor microbiota by Pseudomonas after lung transplantation.
Q49908061Recent perspectives on the molecular basis of biofilm formation by Pseudomonas aeruginosa and approaches for treatment and biofilm dispersal
Q92429968Resistance and Heteroresistance to Colistin in Pseudomonas aeruginosa Isolates from Wenzhou, China
Q46293888Structure, function and regulation of Pseudomonas aeruginosa porins.
Q50261169Susceptibility of Pseudomonas aeruginosa Dispersed Cells to Antimicrobial Agents Is Dependent on the Dispersion Cue and Class of the Antimicrobial Agent Used
Q47406005The ABC of biofilm drug tolerance: The MerR-like regulator BrlR is an activator of ABC transport systems, with PA1874-77 contributing to the tolerance by Pseudomonas aeruginosa biofilms to tobramycin
Q63346843The PA3177 Gene Encodes an Active Diguanylate Cyclase That Contributes to Biofilm Antimicrobial Tolerance but Not Biofilm Formation by Pseudomonas aeruginosa
Q28493140The Pseudomonas aeruginosa diguanylate cyclase GcbA, a homolog of P. fluorescens GcbA, promotes initial attachment to surfaces, but not biofilm formation, via regulation of motility
Q54977625The Yin and Yang of SagS: Distinct Residues in the HmsP Domain of SagS Independently Regulate Biofilm Formation and Biofilm Drug Tolerance.
Q28493226The diguanylate cyclase GcbA facilitates Pseudomonas aeruginosa biofilm dispersion by activating BdlA

Search more.